Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion Stargate Project announced by Trump.

Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's feuded with CEO Sam Altman.

The world's richest man went on a social media tirade against the Open AI chief executive for his former stance on Donald Trump.

OpenAI's Stargate is now the topic of a heated debate between Elon Musk and Sam Altman which are known for having a beef.

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching its nonprofit mandate. Although the lawsuit was withdrawn in June, Musk refiled it in August, further intensifying the conflict.

The company has continued its momentum into 2025, gaining 82% this year and nearly 60% in the last week. Sam Altman first got involved with Oklo in 2014, when he was still the president of startup incubator Y Combinator. In 2015, Altman invested in the company and became its chairman.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

With speculation online about OpenAI having reached the AGI stage of ChatGPT development, Sam Altman says that's not what's happening.

We recently published a list of 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Astera Labs, Inc. (NASDAQ:ALAB) stands against other AI stocks on Wall Street’s radar.

Explore the pros and cons of the first round of technology developments from President Trump's first week in office. What impact will his bold tech moves have?

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines